ethylisopropylamiloride has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, DI; Field, MJ; Johnson, DW; Pollock, CA; Poronnik, P; Saunders, HJ | 1 |
| Bendia, E; Benedetti, A; Casini, A; D'Ambrosio, L; Di Sario, A; Feliciangeli, G; Macarri, G; Pigini, P; Ridolfi, F; Svegliati-Baroni, G; Tonnini, C | 1 |
2 other study(ies) available for ethylisopropylamiloride and transforming growth factor beta
| Article | Year |
|---|---|
Physiological changes in extracellular sodium directly control human proximal tubule growth and transport.
Topics: Aged; Amiloride; Biological Transport; Cell Division; Cells, Cultured; Culture Media, Serum-Free; DNA; Extracellular Space; Female; Growth Substances; Humans; Insulin-Like Growth Factor I; Kidney Tubules, Proximal; Male; Middle Aged; Platelet-Derived Growth Factor; Protein Biosynthesis; Sodium; Sodium-Hydrogen Exchangers; Transforming Growth Factor beta | 1998 |
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study.
Topics: Amiloride; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Ascorbic Acid; Carcinogens; Cell Division; Collagen; Diuretics; Ferric Compounds; Ferrous Compounds; Gene Expression; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Liver; Liver Cirrhosis; Male; Nitrilotriacetic Acid; Procollagen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Sodium-Hydrogen Exchangers; Thymidine Phosphorylase; Transforming Growth Factor beta | 2001 |